Biomea Fusion
Biomea Fusion

Biomea Fusion

hand in laptop pointing to email icon

Your dream job…could be 1 update away

Biomea Fusion Jobs and Salary Info

Find High Paying Jobs, Compensation Information and Expert Network Connections at Biomea Fusion

Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing, and commercializing transformative therapies to treat patients with cancer. Biomea Fusion's lead product candidate, BMF-219, is an oral, selective inhibitor of the fusion of NTRK1, NTRK2, and NTRK3 genes, which is in Phase 1/2 clinical trial for adult patients with solid tumors harboring an NTRK gene fusion. The Company is also developing BMF-119, a selective inhibitor of the fusion of MET exon 14 and other MET alterations. Biomea Fusion, Inc. is based in Brisbane, California.


Market Cap$231.7 million
stats icon
Total value of jobs:
stats icon
Total Jobs:
stats icon
Average Pay:

Biomea Fusion Compensation

Clinical Research Scientist



Average Compensation:$145,833

View All Compensation blue arrow